Vita Life Sciences Limited (ASX:VLS)
1.815
+0.065 (3.71%)
Apr 30, 2025, 10:50 AM AEST
Vita Life Sciences Balance Sheet
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 28.6 | 24.63 | 15.69 | 15.89 | 14.48 | Upgrade
|
Cash & Short-Term Investments | 28.6 | 24.63 | 15.69 | 15.89 | 14.48 | Upgrade
|
Cash Growth | 16.12% | 57.00% | -1.29% | 9.78% | 38.17% | Upgrade
|
Accounts Receivable | 11.71 | 10.7 | 8.65 | 6.83 | 6.49 | Upgrade
|
Other Receivables | 0.29 | 0.51 | 0.33 | 0.28 | 0.45 | Upgrade
|
Receivables | 12 | 11.22 | 8.98 | 7.12 | 6.94 | Upgrade
|
Inventory | 16.6 | 11.15 | 15.41 | 11.31 | 7.13 | Upgrade
|
Prepaid Expenses | 0.77 | 0.59 | 0.61 | 0.48 | 0.39 | Upgrade
|
Other Current Assets | 0.93 | 0.7 | 0.47 | 0.31 | 0.25 | Upgrade
|
Total Current Assets | 58.9 | 48.29 | 41.16 | 35.1 | 29.19 | Upgrade
|
Property, Plant & Equipment | 10.33 | 9.17 | 8.47 | 8.26 | 8.37 | Upgrade
|
Long-Term Deferred Tax Assets | 2.62 | 2.32 | 2.16 | 1.9 | 1.53 | Upgrade
|
Long-Term Deferred Charges | 0.05 | 0.03 | 0.01 | - | 0.01 | Upgrade
|
Total Assets | 71.89 | 59.81 | 51.8 | 45.27 | 39.1 | Upgrade
|
Accounts Payable | 5.58 | 5.58 | 4.5 | 3.82 | 3.09 | Upgrade
|
Accrued Expenses | 2.83 | 2.31 | 2.02 | 2.15 | 1.57 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | 0.34 | Upgrade
|
Current Portion of Leases | 0.3 | 0.21 | 0.3 | 0.19 | 0.27 | Upgrade
|
Current Income Taxes Payable | 0.58 | 0.07 | 0.04 | 0.97 | 0.89 | Upgrade
|
Other Current Liabilities | 9.99 | 8.05 | 8.01 | 7.34 | 6.87 | Upgrade
|
Total Current Liabilities | 19.27 | 16.22 | 14.86 | 14.46 | 13.04 | Upgrade
|
Long-Term Debt | - | - | - | - | 1.16 | Upgrade
|
Long-Term Leases | 0.21 | 0.18 | 0.3 | 0.18 | 0.29 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | - | 0.07 | 0.07 | Upgrade
|
Total Liabilities | 19.61 | 16.48 | 15.3 | 14.85 | 14.66 | Upgrade
|
Common Stock | 45.03 | 42.57 | 41.9 | 41.63 | 41.59 | Upgrade
|
Retained Earnings | 0.85 | -2.77 | -8.48 | -12.53 | -17.93 | Upgrade
|
Comprehensive Income & Other | 6.48 | 3.6 | 3.15 | 1.65 | 1.05 | Upgrade
|
Total Common Equity | 52.35 | 43.4 | 36.57 | 30.75 | 24.72 | Upgrade
|
Minority Interest | -0.07 | -0.07 | -0.07 | -0.33 | -0.28 | Upgrade
|
Shareholders' Equity | 52.28 | 43.33 | 36.5 | 30.42 | 24.44 | Upgrade
|
Total Liabilities & Equity | 71.89 | 59.81 | 51.8 | 45.27 | 39.1 | Upgrade
|
Total Debt | 0.52 | 0.39 | 0.6 | 0.37 | 2.07 | Upgrade
|
Net Cash (Debt) | 28.08 | 24.24 | 15.09 | 15.52 | 12.41 | Upgrade
|
Net Cash Growth | 15.84% | 60.69% | -2.79% | 25.11% | 52.60% | Upgrade
|
Net Cash Per Share | 0.50 | 0.44 | 0.28 | 0.29 | 0.24 | Upgrade
|
Filing Date Shares Outstanding | 56.56 | 56.4 | 56.53 | 55.19 | 54.08 | Upgrade
|
Total Common Shares Outstanding | 56.56 | 56.4 | 56.53 | 55.19 | 54.08 | Upgrade
|
Working Capital | 39.62 | 32.07 | 26.3 | 20.64 | 16.15 | Upgrade
|
Book Value Per Share | 0.93 | 0.77 | 0.65 | 0.56 | 0.46 | Upgrade
|
Tangible Book Value | 52.35 | 43.4 | 36.57 | 30.75 | 24.72 | Upgrade
|
Tangible Book Value Per Share | 0.93 | 0.77 | 0.65 | 0.56 | 0.46 | Upgrade
|
Land | 9.62 | 8.51 | 7.93 | 7.83 | 7.68 | Upgrade
|
Machinery | 2.26 | 1.88 | 1.83 | 1.99 | 2 | Upgrade
|
Construction In Progress | - | 0.48 | - | - | - | Upgrade
|
Leasehold Improvements | 0.3 | 0.12 | 0.13 | 0.14 | 0.12 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.